Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors

Investigative Radiology

Volumn 41, Issue 4, 2006, Pages 415-421

  Lurie, David M ^a   Seguin, Bernard ^b   Schneider, Philip D ^c   Verstraete, Frank J ^b   Wisner, Erik R ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer staging; Contrast assisted ultrasound; Sentinel lymph node; Ultrasound contrast media

Indexed keywords

CONTRAST MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CYTODIAGNOSIS; CANCER LOCALIZATION; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DOG; HEAD AND NECK TUMOR; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; SENTINEL LYMPH NODE; ANIMAL; ANIMAL DISEASE; CANCER STAGING; DOG DISEASE; ECHOGRAPHY; LYMPH NODE; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY;

ANIMALS; CONTRAST MEDIA; DOG DISEASES; DOGS; HEAD AND NECK NEOPLASMS; LYMPH NODES; MICROBUBBLES; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 33746421108     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000201230.29925.95     Document Type: Article

References (45)

1. Liszkay G, Peley G, Sinkovics I, et al. Clinical significance of sentinel lymph node involvement in malignant melanoma. Pathol Oncol Res. 2003;9:184-187.
2. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184-187.
3. Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-1377.
4. Logmans A, Kruyt RH, de Bruin HG, et al. Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: a pilot study. Gynecol Oncol. 1999;75:323-327.
5. Langer S, Guenther JM, Haigh PI, et al. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma. Am Surg. 2004;70:881-885.
6. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002;183:23-27.
7. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991-999.
8. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer. 2001;37:454-458.
9. Schrenk P, Shamiyeh A, Wayand W. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients. Eur J Surg Oncol. 2001;27:378-382.
10. Moskovitz AH, Anderson BO, Yeung RS, et al. Axillary web syndrome after axillary dissection. Am J Surg. 2001;181:434-439.
11. Pitman KT, Felito A, Devaney KO, et al. Sentinel Lymph node biopsy in head and neck cancer. Oral Oncol. 2003;39:343-349.
12. Zervos EE, Burak WE Jr. Lymphatic mapping in solid neoplasms: state of the art. Canc Control. 2002;9:189-202.
13. Vijayakumar V, Boerner PS, Jani AB, et al. A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer. Nucl Med Commun. 2005;26:395-405.
14. Lucci A Jr, Kelemen PR, Miller C, et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg. 2001;192:453-458.
15. Rubio IT, Klimberg VS. Techniques of sentinel lymph node biopsy. Semin Surg Oncol. 2001;20:214-223.
16. Kalady MF, White DC, Fields RC, et al. Validation of delayed sentinel lymph node mapping for melanoma. Cancer J. 2001;7:503-508.
17. Hansen NM. Blue versus hot: learning the techniques with dye and isotopes. Ann Surg Oncol. 2001;8(9 Suppl):64S-66S.
18. Cox CE. Lymphatic mapping in breast cancer: combination technique. Ann Surg Oncol. 2001;8(9 Suppl):67S-70S.
19. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684-689; discussion 689-691.
20. Haigh PI, Glass EC, Essner R. Accuracy of gamma probes in localizing radioactivity: in-vitro assessment and clinical implications. Cancer Biother Radiopharm. 2000;15:561-569.
21. Kropp J, Stein A, Hackert I, et al. Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanoma. Nuklearmedizin. 2001;40:86-90.
22. Misselwitz B, Platzek J, Raduchel B, et al. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. Magma. 1999;8:190-195.
23. Misselwitz B, Sachse A. Interstitial MR lymphography using Gd-carrying liposomes. Acta Radiol Suppl. 1997;412:51-55.
24. Ikomi F, Hanna GK, Schmid-Schonbein GW. Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology. 1995;196:107-113.
25. Harika L, Weissleder R, Poss K, et al. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med. 1995;33:88-92.
26. Fujimoto Y, Okuhata Y, Tyngi S, et al. Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid. Biol Pharm Bull. 2000;23:97-100.
27. Wisner ER, Aho-Sharon KL, Bennett MJ, et al. A modular lymphographic magnetic resonance imaging contrast agent: contrast enhancement with DNA transfection potential. J Med Chem. 1997;40:3992-3996.
28. Wisner ER, Katzberg RW, Link DP, et al. Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model. Acad Radiol. 1996;3:40-48.
29. Wolf GL, Shore MT, Bessin G, et al. Lymph node extraction of radiopaque nanoparticulates in the rabbit as measured in vivo with CT. Acad Radiol. 1999;6:55-60.
30. Tsuda N, Tsuji T, Kato N. Interstitial magnetic resonance lymphography using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid in rabbits with lymph node metastasis. Invest Radiol. 2005;40:306-312.
31. Bergqvist L, Strand SE, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Sem Nuc Med. 1983;13:9-19.
32. Wolf G. Specific imaging agents for lymph nodes. In: Torchilin VP, ed. Handbook of Targeted Delivery of Imaging Agents. Boca Raton, FL: CRC Press; 1995:365-384.
33. Patel D, Dayton P, Gut J, et al. Optical and acoustical interrogation of submicron contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 2002;49:1641-1651.
34. Wisner ER, Ferrara KW, Short RE, et al. Sentinel node detection using contrast-enhanced power Doppler ultrasound lymphography. Invest Radiol. 2003;38:358-365.
35. Wisner ER, Weichert JP, Longino MA, et al. Percutaneous CT lymphography using a new polyiodinated biomimetic microemulsion. Acad Radiol. 2002;9(Suppl 1):S191-S193.
36. Goldberg BB, Merton DA, Liu JB, et al. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology. 2004;230:727-734.
37. Bostick PJ, Giuliano AE. Vital dyes in sentinel node localization. Semin Nucl Med. 2000;30:18-24.
38. Cox CE, Salud C, Whitehead GF, et al. Sentinel lymph node biopsy for breast cancer: combined dye-isotope technique. Breast Canc. 2000;7:389-397.
39. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473-478.
40. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-1190.
41. Glass EC. Nuclear medicine in the detection of the sentinel node. Ann Surg Oncol. 2001;8(9 Suppl):5S-8S.
42. Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med. 2000;30:33-48.
43. Testori A, Bartolomei M, Grana C, et al. Sentinel node localization in primary melanoma: learning curve and results. Melanoma Res. 1999;9:587-593.
44. Sofka CM, Lin D, Adler RS. Advantages of color B-mode imaging with contrast optimization in sonography of low-contrast musculoskeletal lesions and structures in the foot and ankle. J Ultrasound Med. 2005;24:215-218.
45. Evans HE. Miller's Anatomy of the Dog. 3rd ed. Philadelphia: WB Saunders Company; 1993.